Advisors Asset Management Inc. Has $136,000 Stock Holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Advisors Asset Management Inc. boosted its stake in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 27.6% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 1,293 shares of the semiconductor company’s stock after buying an additional 280 shares during the period. Advisors Asset Management Inc.’s holdings in Axcelis Technologies were worth $136,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Signaturefd LLC grew its position in shares of Axcelis Technologies by 348.9% in the second quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock valued at $30,000 after purchasing an additional 164 shares during the last quarter. Blue Trust Inc. boosted its stake in Axcelis Technologies by 223.8% in the 2nd quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock valued at $39,000 after purchasing an additional 188 shares during the period. Ashton Thomas Private Wealth LLC acquired a new position in Axcelis Technologies in the 2nd quarter valued at $39,000. Isthmus Partners LLC increased its position in Axcelis Technologies by 87.3% during the 2nd quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company’s stock worth $47,000 after buying an additional 15,507 shares during the period. Finally, Meeder Asset Management Inc. acquired a new stake in shares of Axcelis Technologies during the second quarter worth $69,000. 89.98% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on ACLS shares. B. Riley lowered their price target on shares of Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd. Needham & Company LLC restated a “hold” rating on shares of Axcelis Technologies in a research report on Friday, November 8th. Finally, Benchmark downgraded shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Friday, November 8th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $167.33.

Axcelis Technologies Price Performance

ACLS stock opened at $74.24 on Friday. The company’s 50-day moving average price is $89.45 and its two-hundred day moving average price is $109.89. The firm has a market cap of $2.41 billion, a P/E ratio of 10.98, a P/E/G ratio of 2.29 and a beta of 1.60. The company has a quick ratio of 3.29, a current ratio of 4.45 and a debt-to-equity ratio of 0.04. Axcelis Technologies, Inc. has a 12 month low of $69.35 and a 12 month high of $158.61.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.